These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 6056366)
1. The Food and Drugs Act and quality assurance of pharmaceutical products. Allmark MG Med Serv J Can; 1967 Mar; 23(3):210-6. PubMed ID: 6056366 [No Abstract] [Full Text] [Related]
2. Regulatory agencies, manufacturers and scientists in assurance of quality drugs. Higuchi T Med Serv J Can; 1967 Mar; 23(3):381-6. PubMed ID: 6056381 [No Abstract] [Full Text] [Related]
3. QUAD routes out inferior drugs. Can Hosp; 1973 May; 50(5):58-9. PubMed ID: 4779804 [No Abstract] [Full Text] [Related]
4. WHO Expert Committee on specifications for pharmaceutical preparations. World Health Organ Tech Rep Ser; 1996; 863():1-194. PubMed ID: 8952445 [TBL] [Abstract][Full Text] [Related]
5. Human and veterinary drugs: good manufacturing practices and proposed exemptions for certain OTC products. Fed Regist; 1978 Sep; 43(190 Pt 2):45013-89. PubMed ID: 10316700 [No Abstract] [Full Text] [Related]
6. Bioequivalence and interchangeability of narrow therapeutic range drugs. Canadian Society for Pharmaceutical Sciences discussion. Palylyk-Colwell E; Jamali F; Dryden W; Friesen E; Koven S; Mohamed I; Osmond B; Alessi-Severini S; Sheldon L; Sheldon R; Tam Y; Tsuyuki R; Zhanel G J Pharm Pharm Sci; 1998; 1(1):2-7. PubMed ID: 10942966 [No Abstract] [Full Text] [Related]
7. National drug quality assurance system. Wijesekera T Ceylon Med J; 1993 Jun; 38(2):58-60. PubMed ID: 8370088 [No Abstract] [Full Text] [Related]
8. WHO Expert Committee on Specifications for Pharmaceutical Preparations. World Health Organization World Health Organ Tech Rep Ser; 2005; 929():1-142, backcover. PubMed ID: 16353684 [TBL] [Abstract][Full Text] [Related]
11. Enforcement of the current good manufacturing practices for solid oral dosage forms after United States v. Barr Laboratories. Jimenez FA Food Drug Law J; 1997; 52(1):67-82. PubMed ID: 10346711 [No Abstract] [Full Text] [Related]
12. 'The nature, substance and quality demanded'. Hartley F Ann R Coll Surg Engl; 1980 Mar; 62(2):142-5. PubMed ID: 7377689 [No Abstract] [Full Text] [Related]
13. WHO expert committee on specifications for pharmaceutical preparations. Fortieth report. WHO Expert Committee on Specifications for Pharmaceutical Preparations World Health Organ Tech Rep Ser; 2006; 937():1-461, back cover. PubMed ID: 16836287 [TBL] [Abstract][Full Text] [Related]
14. The relation of pharmaceutical education to the quality assurance of pharmaceutical products. Gaudry R Med Serv J Can; 1967 Mar; 23(3):376-80. PubMed ID: 6056380 [No Abstract] [Full Text] [Related]
15. [Guidelines for introducing new drugs for medical use in Poland and control of their quality]. Danysz A Pol Tyg Lek; 1984 Dec 17-31; 39(51-52):1673-4. PubMed ID: 6522321 [No Abstract] [Full Text] [Related]
16. WHO Expert Committee on Specifications for Pharmaceutical Preparations. World Health Organ Tech Rep Ser; 1999; 885():i-vi, 1-156. PubMed ID: 10352573 [TBL] [Abstract][Full Text] [Related]
17. Preclearance of drug products--pharmacy's perspective. Feldmann EG Am Pharm; 1981 Jun; NS21(6):26-32. PubMed ID: 7246421 [No Abstract] [Full Text] [Related]
18. Antibiotics standards versus standards for other drugs. Wright WW Am J Hosp Pharm; 1982 Jun; 39(6):1046-7. PubMed ID: 7102691 [No Abstract] [Full Text] [Related]